Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Neurotrauma Reports is Scopus-indexed (Q3, CiteScore 2.8), WoS ESCI, DOAJ. Published by SAGE Publications Ltd.
Checked against the index lists dated .
ISSN 2689-288XVerify ISSN ↗
Publisher: SAGE Publications Ltd
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Developmental Neuroscience | 27 / 38 | 30th | Q3 |
| Cellular and Molecular Neuroscience | 82 / 102 | 20th | Q4 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2020–present, best quartile Q3, CiteScore 2.8.
Neurotrauma Reports is Q3 in Developmental Neuroscience (rank 27 of 38) and Q4 in Cellular and Molecular Neuroscience (rank 82 of 102), by CiteScore 2025.
Neurotrauma Reports is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 2.8, which places it in quartile Q3 at the 30th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.654, quartile Q3, with an H-index of 18.
The publisher lists an article processing charge of about US$1,750 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Neurotrauma Reports is published by SAGE Publications Ltd. Its ISSN is 2689-288X.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Neurotrauma Reports has an h-index of 22 and a 2-year mean of 1.72 citations per paper (OpenAlex). Its Scopus CiteScore is 2.8, quartile Q3. On 2-year citations it ranks #20 of 37 Scopus journals in Developmental Neuroscience.
Neurotrauma Reports published 89 papers in 2025; its busiest recent year was 2024 with 106. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2025–2026), authors are most often from United States (72.2%), Canada (12.3%) and Australia (2.3%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (3.9 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.